A Study of Olanzapine in Participants With Bipolar Disorder.

Clinical trial NCT07263191 · RECRUITING

Trial details

NCT number: NCT07263191
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: RECRUITING
Study type: OBSERVATIONAL

Bipolar Disorder

Start date: 2025-10-30
Primary completion: 2027-09-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.